Document Detail


Endothelial dysfunction enhances the pulmonary and systemic vasodilator effects of phosphodiesterase-5 inhibition in awake swine at rest and during treadmill exercise.
MedLine Citation:
PMID:  22312057     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiovascular disease is characterized by impaired exercise capacity and endothelial dysfunction, i.e. reduced bioavailability of nitric oxide (NO). Phosphodiesterase-5 (PDE5) inhibition is a promising vasodilator therapy, but its effects on pulmonary and systemic hemodynamic responses to exercise in the absence, and particularly in the presence, of endothelial dysfunction have not been studied. We investigated the effects of PDE5 inhibitor EMD360527 in chronically instrumented swine at rest and during exercise with and without NO synthase inhibition (N(ω)-nitro-l-arginine; NLA). PDE5 inhibition caused a 19 ± 3% decrease in systemic vascular resistance (SVR) and a 24 ± 4% decrease in pulmonary vascular resistance (PVR) at rest. At maximal exercise, PDE5 inhibition caused a 13 ± 1% decrease in SVR and a 29 ± 3% decrease in PVR. NLA enhanced PDE5-inhibition-induced pulmonary (decrease in PVR 32 ± 12% at rest and 41 ± 3% during exercise) and systemic (decrease in SVR 24 ± 5% at rest and 18 ± 3% during exercise) vasodilation. Similarly, NLA increased the pulmonary and systemic vasodilation to nitroprusside and 8-bromo-cyclic guanosine monophosphate (cGMP), indicating that inhibition of NO synthase increases responsiveness to stimulation of the NO/cGMP pathway. Thus, PDE5 inhibition causes pulmonary and systemic vasodilation that is, respectively, maintained and slightly blunted during exercise. The degree of dilation in both the pulmonary and systemic beds were paradoxically enhanced in the presence of reduced bioavailability of NO, suggesting that this vasodilator therapy is most effective in patients with cardiovascular disease.
Authors:
Birgit Houweling; Johan Quispel; Norbert Beier; Pieter D Verdouw; Dirk J Duncker; Daphne Merkus
Related Documents :
1591797 - The relationship of osteoarthritis and exercise.
22816087 - Effect of regular physical training on hemopoiesis in experimental animals.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-02-06
Journal Detail:
Title:  Experimental biology and medicine (Maywood, N.J.)     Volume:  237     ISSN:  1535-3699     ISO Abbreviation:  Exp. Biol. Med. (Maywood)     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-22     Completed Date:  2012-04-09     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  100973463     Medline TA:  Exp Biol Med (Maywood)     Country:  England    
Other Details:
Languages:  eng     Pagination:  201-10     Citation Subset:  IM    
Affiliation:
Experimental Cardiology, Thoraxcenter, Cardiovascular Research Institute COEUR, Erasmus University Medical Center, Dr Molewaterplein 50, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cyclic GMP / analogs & derivatives,  metabolism
Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism
Endothelial Cells / cytology*
Humans
Hypertension, Pulmonary / drug therapy
Nitric Oxide / chemistry
Nitric Oxide Synthase / metabolism
Nitroprusside / pharmacology
Phosphodiesterase 5 Inhibitors / pharmacology*
Physical Conditioning, Animal*
Pulmonary Circulation
Swine
Vascular Resistance
Chemical
Reg. No./Substance:
0/Phosphodiesterase 5 Inhibitors; 10102-43-9/Nitric Oxide; 15078-28-1/Nitroprusside; 31356-94-2/8-bromocyclic GMP; 7665-99-8/Cyclic GMP; EC 1.14.13.39/Nitric Oxide Synthase; EC 3.1.4.35/Cyclic Nucleotide Phosphodiesterases, Type 5

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Host genetics and population structure effects on parasitic disease.
Next Document:  Effects of selenium on the vessel walls and anti-elastin antibodies in spontaneously hypertensive ra...